PubRank

Marcus N Scherer

Author PubWeight™ 45.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012 19.78
2 Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2009 1.57
3 Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol 2013 1.56
4 Strong predictors for alcohol recidivism after liver transplantation: non-acceptance of the alcohol problem and abstinence of <3 months. Scand J Gastroenterol 2011 1.55
5 Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 2004 1.40
6 Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab 2010 1.13
7 Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Scand J Gastroenterol 2010 1.03
8 Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis. Cytokine 2010 0.95
9 Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol 2011 0.86
10 Unconventional RORγt+ T cells drive hepatic ischemia reperfusion injury. J Immunol 2013 0.84
11 Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation. Trials 2012 0.83
12 Adult living donor liver transplantation: body mass index and MELD score of recipients are independent risk factors for hospital mortality. Langenbecks Arch Surg 2008 0.83
13 Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival. Hepatology 2011 0.82
14 Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvascularization of malignant liver lesions before surgery or radiofrequeny ablation. Clin Hemorheol Microcirc 2012 0.82
15 Liver transplantation for sclerosing cholangitis in a polytraumatized patient. Nat Clin Pract Gastroenterol Hepatol 2008 0.81
16 Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. Eur J Clin Invest 2013 0.81
17 Clinical management of patients receiving cell-based immunoregulatory therapy. Transfusion 2014 0.79
18 Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment. Eur Surg Res 2010 0.79
19 Glucose-6-phosphate dehydrogenase deficiency: a contraindication for living donor liver transplantation? Transpl Int 2010 0.79
20 Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience. J Transplant 2010 0.79
21 Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study. BMC Nephrol 2010 0.78
22 The antineoplastic drug Paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model. Transplantation 2002 0.78
23 Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion. Transplant Res 2013 0.78
24 Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity? Transpl Immunol 2011 0.77
25 "Rescue allocation offers" in liver transplantation: is there any reason to reject "unwanted" organs? Scand J Gastroenterol 2010 0.77
26 Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury. Regul Pept 2012 0.77
27 Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function. Cytokine 2011 0.77
28 AAV plasmid DNA simplifies liver-directed in vivo gene therapy: comparison of expression levels after plasmid DNA-, adeno-associated virus- and adenovirus-mediated liver transfection. J Gene Med 2010 0.75
29 Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients. Hum Immunol 2002 0.75
30 Alcohol recidivism after liver transplantation. Scand J Gastroenterol 2014 0.75
31 Targeting of interleukin-10 is superior to cytotoxic T-lymphocyte associated antigen 4 with human immunoglobulin G(1) for the prevention of chronic allograft deterioration in organ transplantation. J Gene Med 2008 0.75
32 Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro. Exp Mol Pathol 2011 0.75
33 Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients. Hum Immunol 2002 0.75
34 Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07). Transplantation 2015 0.75
35 Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer. Transpl Int 2003 0.75
36 Portal levels of latent transforming growth factor-β are related to liver function in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2011 0.75
37 Percutaneous laparoscopic assisted gastrostomy (PLAG)--a new technique for cases of pharyngoesophageal obstruction. Langenbecks Arch Surg 2010 0.75